Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Avascular Necrosis of Hip clinical trials
2 of 5 indexed Avascular Necrosis of Hip trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Avascular Necrosis of Hip: 5 US clinical trials tracked, 2 recruiting.
Avascular Necrosis of Hip is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Zimmer Biomet, running 3 of these trials.
Enrollment posture brief
Registry condition avascular-necrosis-of-hip
OPEN 2 | RECR 40% | LATE 0 | EARLY 0 | RANK #3391 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Avascular Necrosis of Hip lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Avascular Necrosis of Hip on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Avascular Necrosis of Hip is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Avascular Necrosis of Hip research.
Zimmer Biomet accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.
-
Typical Avascular Necrosis of Hip enrolment sits around 288 participants.
Median target enrolment is 288 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Avascular Necrosis of Hip splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
Zimmer Biomet
NCT04754087
Safety and Effectiveness of the HIT Reverse HRS
Hip Innovation Technology
NCT05357378
Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment
Mayo Clinic
NCT06891196
Avenir Complete Post-Market Clinical Follow-Up Study
Zimmer Biomet
NCT04731077
SCP Hip Outcomes Study
Zimmer Biomet
NCT03494660
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Avascular Necrosis of Hip records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Avascular Necrosis of Hip trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Avascular Necrosis of Hip page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Avascular Necrosis of Hip trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Zimmer Biomet sponsors the most Avascular Necrosis of Hip trials on record, review their full trial history before evaluating a specific study. See Zimmer Biomet's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Avascular Necrosis of Hip condition card totals 5 registered trials; most-linked intervention Avenir Complete Femoral Stem; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.